• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌患者放射性碘治疗后唾液腺功能的迟发副作用。

Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.

机构信息

Department of Head and Neck Surgery and Otorhinolaryngology, Hospital A.C. Camargo, São Paulo, Brazil.

出版信息

Head Neck. 2011 May;33(5):686-90. doi: 10.1002/hed.21520. Epub 2010 Nov 10.

DOI:10.1002/hed.21520
PMID:21484917
Abstract

BACKGROUND

The purpose of this study was to assess the late side effects of radioiodine therapy (RIT) on salivary gland function. One hundred eighty two patients were evaluated.

METHODS

Assessment of salivary gland function was performed with salivary gland scintigraphy (SGS), sialometry, and subjective open questions to determine common side effects of RIT on salivary gland function.

RESULTS

RIT had a strong association with decreased elimination counts by SGS. Patient age was the only variable associated with sialometry; age and the use of xerostomic drugs were strongly associated with decreased mean values of salivary flow. Dysphagia was strongly associated with RIT. Using multiple logistic regression analysis, age was determined to be an important factor associated with salivary gland dysfunction, and RIT was associated with impairment of saliva excretion.

CONCLUSION

These results show that patients subjected to RIT have more difficulty in draining saliva, mainly from the parotid glands, which is associated with clinical dysphagia in this subset of patients.

摘要

背景

本研究旨在评估放射性碘治疗 (RIT) 对唾液腺功能的晚期副作用。对 182 名患者进行了评估。

方法

通过唾液腺闪烁扫描 (SGS)、唾液量测定和主观开放性问题评估唾液腺功能,以确定 RIT 对唾液腺功能的常见副作用。

结果

RIT 与 SGS 中排泄计数的减少有很强的相关性。患者年龄是唯一与唾液量测定相关的变量;年龄和使用口干药物与唾液流量的平均值显著降低相关。吞咽困难与 RIT 强烈相关。使用多元逻辑回归分析,年龄被确定为与唾液腺功能障碍相关的重要因素,RIT 与唾液排泄功能受损相关。

结论

这些结果表明,接受 RIT 的患者在排出唾液方面存在更多困难,主要来自腮腺,这与该患者亚组的临床吞咽困难有关。

相似文献

1
Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.甲状腺癌患者放射性碘治疗后唾液腺功能的迟发副作用。
Head Neck. 2011 May;33(5):686-90. doi: 10.1002/hed.21520. Epub 2010 Nov 10.
2
Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.放射性碘治疗后甲状腺癌患者唾液腺功能障碍的闪烁显像评估
Clin Nucl Med. 2002 Nov;27(11):767-71. doi: 10.1097/00003072-200211000-00003.
3
Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.分化型甲状腺癌患者放射性碘消融后 5 年的唾液腺功能:消融前后闪烁显像的直接比较及其与口干症状的关系。
Thyroid. 2013 May;23(5):609-16. doi: 10.1089/thy.2012.0106. Epub 2013 Apr 18.
4
Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.氨磷汀在高剂量放射性碘治疗中对唾液腺的放射防护作用。一项针对分化型甲状腺癌患者的双盲、安慰剂对照研究的结果。
Strahlenther Onkol. 1999 Nov;175 Suppl 4:6-12.
5
Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.氨磷汀在高剂量放射性碘治疗中对唾液腺的保护作用:一项双盲安慰剂对照研究的结果。
J Clin Oncol. 1998 Nov;16(11):3542-9. doi: 10.1200/JCO.1998.16.11.3542.
6
Risk Factors of I-Induced Salivary Gland Damage in Thyroid Cancer Patients.甲状腺癌患者放射性碘诱导唾液腺损伤的危险因素。
J Clin Endocrinol Metab. 2016 Nov;101(11):4085-4093. doi: 10.1210/jc.2016-1605. Epub 2016 Aug 17.
7
Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose.全甲状腺切除术后患者接受放射性碘(I-131)治疗后的唾液腺功能障碍:重点关注放射性碘治疗剂量。
Clin Imaging. 2015 May-Jun;39(3):396-400. doi: 10.1016/j.clinimag.2014.12.018. Epub 2015 Jan 7.
8
Salivary evaluation in radioactive I treated patients with thyroid carcinoma.放射性碘治疗的甲状腺癌患者的唾液评估。
Acta Odontol Scand. 2018 Mar;76(2):148-152. doi: 10.1080/00016357.2017.1399214. Epub 2017 Nov 10.
9
Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.氨磷汀在高剂量放射性碘治疗中对唾液腺的辐射防护作用。
J Nucl Med. 1998 Jul;39(7):1237-42.
10
Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.涎腺内镜治疗慢性放射性碘诱发涎腺炎后的涎腺功能
Head Neck. 2016 Jan;38(1):51-8. doi: 10.1002/hed.23844. Epub 2015 Jan 27.

引用本文的文献

1
Advances in the selection and timing of postoperative radioiodine treatment in patients with differentiated thyroid carcinoma.分化型甲状腺癌患者术后碘-131 治疗的选择和时机的进展。
Ann Nucl Med. 2024 Sep;38(9):688-699. doi: 10.1007/s12149-024-01963-z. Epub 2024 Jul 24.
2
Iodine-125 seed inhibits proliferation and promotes apoptosis of cholangiocarcinoma cells by inducing the ROS/p53 axis.碘-125 种子通过诱导 ROS/p53 轴抑制胆管癌细胞增殖并促进其凋亡。
Funct Integr Genomics. 2024 Jun 12;24(3):114. doi: 10.1007/s10142-024-01392-1.
3
Value of radiofrequency ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis for 2-year follow-up.
射频消融治疗局部复发性甲状腺癌的价值:2 年随访的系统评价和荟萃分析。
Endocrine. 2024 Sep;85(3):1066-1074. doi: 10.1007/s12020-023-03660-9. Epub 2024 May 27.
4
Radiofrequency ablation versus radioactive iodine: the race for the best cure.射频消融术与放射性碘:最佳治疗方法之争。
Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):2047-2049. doi: 10.1007/s00259-024-06679-w.
5
Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy.放射性碘治疗后口干的分化型甲状腺癌患者口腔微生物组的改变。
Front Endocrinol (Lausanne). 2022 Aug 26;13:895970. doi: 10.3389/fendo.2022.895970. eCollection 2022.
6
Quantitative Scintigraphy Evaluated the Relationship between 131I Therapy and Salivary Glands Function in DTC Patients: A Retrospective Analysis.定量闪烁扫描评估 131I 治疗与 DTC 患者唾液腺功能的关系:回顾性分析。
J Healthc Eng. 2022 Apr 14;2022:7640405. doi: 10.1155/2022/7640405. eCollection 2022.
7
The RAI-6 Questionnaire: A New Screening Questionnaire to Monitor Complications of Radioiodine Treatment.RAI-6问卷:一种用于监测放射性碘治疗并发症的新型筛查问卷。
Front Surg. 2021 Sep 1;8:641945. doi: 10.3389/fsurg.2021.641945. eCollection 2021.
8
A pretest-posttest pilot study for the development and preliminary validation of a tool for the clinical assessment of radioiodine induced sialadenitis.一项关于放射性碘诱发涎腺炎临床评估工具开发与初步验证的前后测试点研究。
SAGE Open Med. 2021 Sep 1;9:20503121211042211. doi: 10.1177/20503121211042211. eCollection 2021.
9
Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?涎腺炎作为甲状腺癌患者放射性碘治疗的并发症:我们目前的情况如何?
Hormones (Athens). 2021 Dec;20(4):669-678. doi: 10.1007/s42000-021-00304-3. Epub 2021 Jun 18.
10
6,8-Diprenylorobol Induces Apoptosis in Human Hepatocellular Carcinoma Cells via Activation of FOXO3 and Inhibition of CYP2J2.6,8-二异戊烯基橙酮通过激活 FOXO3 和抑制 CYP2J2 诱导人肝癌细胞凋亡。
Oxid Med Cell Longev. 2020 Nov 19;2020:8887251. doi: 10.1155/2020/8887251. eCollection 2020.